{"abstract":"The Food and Drug Administration (FDA or Agency) is providing interested persons with the opportunity to submit comments about the World Health Organization (WHO) recommendations to impose international manufacturing and distributing restrictions, under international treaties, on certain drug substances. The comments received in response to this notice will be considered in preparing the United States' position on these proposals for a meeting of the United Nations Commission on Narcotic Drugs (CND) in Vienna, Austria, March 18-22, 2019. This notice is issued under the Controlled Substances Act (CSA).","action":"Notice; request for comments.","agencies":[{"raw_name":"DEPARTMENT OF HEALTH AND HUMAN SERVICES","name":"Health and Human Services Department","id":221,"url":"https://www.federalregister.gov/agencies/health-and-human-services-department","json_url":"https://www.federalregister.gov/api/v1/agencies/221","parent_id":null,"slug":"health-and-human-services-department"},{"raw_name":"Food and Drug Administration","name":"Food and Drug Administration","id":199,"url":"https://www.federalregister.gov/agencies/food-and-drug-administration","json_url":"https://www.federalregister.gov/api/v1/agencies/199","parent_id":221,"slug":"food-and-drug-administration"}],"body_html_url":"https://www.federalregister.gov/documents/full_text/html/2019/03/01/2019-03662.html","cfr_references":[],"citation":"84 FR 7064","comment_url":null,"comments_close_on":"2019-03-14","correction_of":null,"corrections":[],"dates":"Submit either electronic or written comments on the notice by March 14, 2019. The short time period for the submission of comments is needed to ensure that the U.S. Department of Health and Human Services (HHS) may, in a timely fashion, carry out the required action and be responsive to the United Nations.","disposition_notes":null,"docket_ids":["Docket No. FDA-2019-N-0767"],"dockets":[{"supporting_documents":[],"agency_name":"FDA","documents":[{"comment_count":3566,"comment_start_date":"2019-03-01","updated_at":"2023-02-28T18:25:23.093-05:00","comment_url":"https://www.regulations.gov/commenton/FDA-2019-N-0767-0001","allow_late_comments":null,"id":"FDA-2019-N-0767-0001","comment_end_date":"2019-10-01","regulations_dot_gov_open_for_comment":false}],"supporting_documents_count":0,"id":"FDA-2019-N-0767","title":"International Drug Scheduling; Convention on Psychotropic Substances; Single Convention on Narcotic Drugs; World Health Organization; Scheduling Recommendations; Cannabis and cannabis resin; Dronabinol (delta-9-tetrahydrocannabinol); Tetrahydrocannabinol (Isomers of delta-9-tetrahydrocannabinol); Extracts and tinctures of cannabis; Cannabidiol preparations; Pharmaceutical preparations produced eit"}],"document_number":"2019-03662","effective_on":null,"end_page":7070,"executive_order_notes":null,"executive_order_number":null,"explanation":null,"full_text_xml_url":"https://www.federalregister.gov/documents/full_text/xml/2019/03/01/2019-03662.xml","html_url":"https://www.federalregister.gov/documents/2019/03/01/2019-03662/international-drug-scheduling-convention-on-psychotropic-substances-single-convention-on-narcotic","images":{},"images_metadata":{},"json_url":"https://www.federalregister.gov/api/v1/documents/2019-03662?publication_date=2019-03-01","mods_url":"https://www.govinfo.gov/metadata/granule/FR-2019-03-01/2019-03662/mods.xml","not_received_for_publication":null,"page_length":7,"page_views":{"count":3438,"last_updated":"2026-04-03 20:15:04 -0400"},"pdf_url":"https://www.govinfo.gov/content/pkg/FR-2019-03-01/pdf/2019-03662.pdf","presidential_document_number":null,"proclamation_number":null,"public_inspection_pdf_url":"https://public-inspection.federalregister.gov/2019-03662.pdf?1551361528","publication_date":"2019-03-01","raw_text_url":"https://www.federalregister.gov/documents/full_text/text/2019/03/01/2019-03662.txt","regulation_id_number_info":{},"regulation_id_numbers":[],"regulations_dot_gov_info":{"supporting_documents":[],"comments_count":3566,"agency_id":"FDA","comments_url":"https://www.regulations.gov/docketBrowser?rpp=50&so=DESC&sb=postedDate&po=0&dct=PS&D=FDA-2019-N-0767","supporting_documents_count":0,"docket_id":"FDA-2019-N-0767","document_id":"FDA-2019-N-0767-0001","regulation_id_number":null,"title":"International Drug Scheduling; Convention on Psychotropic Substances; Single Convention on Narcotic Drugs; World Health Organization; Scheduling Recommendations; Cannabis and cannabis resin; Dronabinol (delta-9-tetrahydrocannabinol); Tetrahydrocannabinol (Isomers of delta-9-tetrahydrocannabinol); Extracts and tinctures of cannabis; Cannabidiol preparations; Pharmaceutical preparations produced eit","checked_regulationsdotgov_at":"2023-02-28T23:25:22Z"},"regulations_dot_gov_url":null,"significant":null,"signing_date":null,"start_page":7064,"subtype":null,"title":"International Drug Scheduling; Convention on Psychotropic Substances; Single Convention on Narcotic Drugs; World Health Organization; Scheduling Recommendations; Dronabinol (delta-9-tetrahydrocannabinol) and its Stereoisomers; Cannabis, Cannabis Resin, Extracts and Tinctures; Cannabidiol Preparations; and Pharmaceutical Preparations of Cannabis; Request for Comments","toc_doc":"Dronabinol (delta-9-tetrahydrocannabinol) and its Stereoisomers; Cannabis, Cannabis Resin, Extracts and Tinctures; Cannabidiol Preparations; and Pharmaceutical Preparations of Cannabis","toc_subject":"International Drug Scheduling; Convention on Psychotropic Substances; Single Convention on Narcotic Drugs; World Health Organization; Scheduling Recommendations:","topics":[],"type":"Notice","volume":84}